181 related articles for article (PubMed ID: 12813057)
1. Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation.
Sun Y; Qi X; Grabowski GA
J Biol Chem; 2003 Aug; 278(34):31918-23. PubMed ID: 12813057
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
[TBL] [Abstract][Full Text] [Related]
3. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
Qi X; Leonova T; Grabowski GA
J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants.
Sun Y; Quinn B; Witte DP; Grabowski GA
J Lipid Res; 2005 Oct; 46(10):2102-13. PubMed ID: 16061944
[TBL] [Abstract][Full Text] [Related]
5. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
[TBL] [Abstract][Full Text] [Related]
6. Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.
Sun Y; Ran H; Zamzow M; Kitatani K; Skelton MR; Williams MT; Vorhees CV; Witte DP; Hannun YA; Grabowski GA
Hum Mol Genet; 2010 Feb; 19(4):634-47. PubMed ID: 20015957
[TBL] [Abstract][Full Text] [Related]
7. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
Ambrosi G; Ghezzi C; Zangaglia R; Levandis G; Pacchetti C; Blandini F
Neurobiol Dis; 2015 Oct; 82():235-242. PubMed ID: 26094596
[TBL] [Abstract][Full Text] [Related]
8. Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites.
Fabbro D; Grabowski GA
J Biol Chem; 1991 Aug; 266(23):15021-7. PubMed ID: 1714449
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
Lamontagne S; Potier M
J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
[TBL] [Abstract][Full Text] [Related]
11. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
[TBL] [Abstract][Full Text] [Related]
12. Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice.
Sun Y; Qi X; Witte DP; Ponce E; Kondoh K; Quinn B; Grabowski GA
Mol Genet Metab; 2002 Aug; 76(4):271-86. PubMed ID: 12208132
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
14. Saposin A: second cerebrosidase activator protein.
Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Pavan E; Peruzzo P; Cattarossi S; Bergamin N; Bordugo A; Sechi A; Scarpa M; Biasizzo J; Colucci F; Dardis A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928321
[TBL] [Abstract][Full Text] [Related]
16. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions.
Qi X; Qin W; Sun Y; Kondoh K; Grabowski GA
J Biol Chem; 1996 Mar; 271(12):6874-80. PubMed ID: 8636113
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
18. Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.
Liou B; Zhang W; Fannin V; Quinn B; Ran H; Xu K; Setchell KDR; Witte D; Grabowski GA; Sun Y
Sci Rep; 2019 Apr; 9(1):5571. PubMed ID: 30944381
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
[TBL] [Abstract][Full Text] [Related]
20. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells.
Harzer K; Paton BC; Christomanou H; Chatelut M; Levade T; Hiraiwa M; O'Brien JS
FEBS Lett; 1997 Nov; 417(3):270-4. PubMed ID: 9409731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
